StockData
Hyperfine, Inc. logo

Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3021% below fair value
$0.61−0.02 (-3.05%)

Close on Nov 16, 2026Market cap $64.70MP/E –Yield –

Hyperfine cash

Cash and short-term investments held at the end of each period.

Hyperfine's cash was $43.46M at Jun 30, 2026. For fiscal 2025 it was $35.09M, down 6.9% from the year before. The highest annual figure on record is $191.16M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$35.09M-6.9%
FY2024Dec 31, 2024$37.67M-50.3%
FY2023Dec 31, 2023$75.80M-35.9%
FY2022Dec 31, 2022$118.24M-38.1%
FY2021Dec 31, 2021$191.16M+197.4%
FY2020Dec 31, 2020$64.29M+143.1%
FY2019Dec 31, 2019$26.44M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$43.46M+71.0%
Q1 FY2026Mar 31, 2026$40.78M+23.2%
Q4 FY2025Dec 31, 2025$35.09M-6.9%
Q3 FY2025Sep 30, 2025$21.56M-52.9%
Q2 FY2025Jun 30, 2025$25.42M-52.8%
Q1 FY2025Mar 31, 2025$33.09M-47.6%
Q4 FY2024Dec 31, 2024$37.67M-50.3%
Q3 FY2024Sep 30, 2024$45.77M-46.4%
Q2 FY2024Jun 30, 2024$53.81M-42.7%
Q1 FY2024Mar 31, 2024$63.20M-39.2%
Q4 FY2023Dec 31, 2023$75.80M-35.9%
Q3 FY2023Sep 30, 2023$85.42M-35.5%
Q2 FY2023Jun 30, 2023$93.95M-35.3%
Q1 FY2023Mar 31, 2023$104.03M-35.6%
Q4 FY2022Dec 31, 2022$118.24M-38.1%
Q3 FY2022Sep 30, 2022$132.48M+102.3%
Q2 FY2022Jun 30, 2022$145.10M+87.5%
Q1 FY2022Mar 31, 2022$161.58M+87.4%
Q4 FY2021Dec 31, 2021$191.16M+197.4%
Q3 FY2021Sep 30, 2021$65.48M+147.6%
Q2 FY2021Jun 30, 2021$77.39M–
Q1 FY2021Mar 31, 2021$86.23M–
Q4 FY2020Dec 31, 2020$64.29M–
Q4 FY2019Dec 31, 2019$26.44M–

More Hyperfine figures

See a number that looks wrong?